Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Altimmune Inc (NASDAQ: ALT) closed at $3.52 down -2.22% from its previous closing price of $3.6. In other words, the price has decreased by -$2.22 from its previous closing price. On the day, 2.43 million shares were traded. ALT stock price reached its highest trading level at $3.68 during the session, while it also had its lowest trading level at $3.49.
Ratios:
For a deeper understanding of Altimmune Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.82 and its Current Ratio is at 15.82. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 17 ’25 when Sohn Catherine A. bought 1,000 shares for $5.78 per share. The transaction valued at 5,784 led to the insider holds 1,000 shares of the business.
WEAVER GREGORY L bought 10,000 shares of ALT for $51,996 on Mar 13 ’25. The Chief Financial Officer now owns 10,000 shares after completing the transaction at $5.20 per share. On Aug 19 ’24, another insider, Drutz David, who serves as the Director of the company, sold 16,011 shares for $6.90 each. As a result, the insider received 110,547 and left with 41,958 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALT now has a Market Capitalization of 292400416 and an Enterprise Value of 137257552. For the stock, the TTM Price-to-Sale (P/S) ratio is 14275.07 while its Price-to-Book (P/B) ratio in mrq is 1.93. Its current Enterprise Value per Revenue stands at 6862.877 whereas that against EBITDA is -1.4.
Stock Price History:
The Beta on a monthly basis for ALT is 0.18, which has changed by -0.42949754 over the last 52 weeks, in comparison to a change of 0.18634176 over the same period for the S&P500. Over the past 52 weeks, ALT has reached a high of $11.16, while it has fallen to a 52-week low of $2.90. The 50-Day Moving Average of the stock is -29.15%, while the 200-Day Moving Average is calculated to be -42.88%.
Shares Statistics:
For the past three months, ALT has traded an average of 5.64M shares per day and 2546830 over the past ten days. A total of 81.11M shares are outstanding, with a floating share count of 80.26M. Insiders hold about 1.04% of the company’s shares, while institutions hold 47.92% stake in the company. Shares short for ALT as of 1752537600 were 28097407 with a Short Ratio of 4.98, compared to 1749772800 on 24400612. Therefore, it implies a Short% of Shares Outstanding of 28097407 and a Short% of Float of 34.910000000000004.
Earnings Estimates
The current rating of Altimmune Inc (ALT) reflects the combined expertise of 8.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.24 and low estimates of -$0.37.
Analysts are recommending an EPS of between -$0.86 and -$1.38 for the fiscal current year, implying an average EPS of -$1.23. EPS for the following year is -$1.46, with 6.0 analysts recommending between -$0.99 and -$1.89.
